Canopy Growth showed improved performance, but still reported a net loss due to high operating costs. Read why I rate CGC ...

Aurora Cannabis Inc. (TSE:ACB – Get Free Report) has earned an average recommendation of “Moderate Buy” from the five brokerages that are currently covering the company, MarketBeat.com reports. Three ...

US stocks have risen this year, but traders are hedging against big swings induced by Trump’s erratic policymaking ...

Roth/MKM maintained a positive stance on Canopy Growth (NASDAQ:CGC) shares, despite reducing the price target to C$10 from the previous C$15. The firm continues to endorse a Buy rating for the ...

Profit after tax tumbled to $381 million in 2024 from $15.2 billion in 2023, owing to weaker refining margins, asset ...

As a leader in the medical cannabis space, Aurora Cannabis is enjoying premium margins. Read why I rate ACB stock a Strong ...

Medical cannabis company Aurora Cannabis (ACB) has surprised markets with a record-breaking third quarter, sending its shares ...

Analysts at Roth Capital issued their Q1 2026 earnings per share estimates for shares of Aurora Cannabis in a research report issued on Thursday, February 6th. Roth Capital analyst W. Kirk expects ...

“Results were below our forecast despite in-line revenue, and compensation being lower than our forecast. Non-compensation ...

KR's stock price experienced a rise due to the ... reinstated a “Buy” rating on KR with a $70 price target, implying a potential upside of 7% from current levels. The mean price target of ...

In a report released today, Bill Kirk from Roth MKM reiterated a Hold rating on Aurora Cannabis (ACB – Research Report), with a price target of ...

Prices aren't coming down ... And when it does, that can be great news for Target, especially given its modest valuation. Target's stock hasn't been soaring over the past year, which isn't ...